These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 23298508)

  • 1. Comparitive effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study.
    Rossi A; Mari E; Scarno M; Garelli V; Maxia C; Scali E; Iorio A; Carlesimo M
    Int J Immunopathol Pharmacol; 2012; 25(4):1167-73. PubMed ID: 23298508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of male androgenetic alopecia with topical products containing Serenoa repens extract.
    Wessagowit V; Tangjaturonrusamee C; Kootiratrakarn T; Bunnag T; Pimonrat T; Muangdang N; Pichai P
    Australas J Dermatol; 2016 Aug; 57(3):e76-82. PubMed ID: 26010505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of long-term efficacy of finasteride in Korean men with androgenetic alopecia using the basic and specific classification system.
    Shin JW; Chung EH; Kim MB; Kim TO; Kim WI; Huh CH
    J Dermatol; 2019 Feb; 46(2):139-143. PubMed ID: 30536893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia.
    Boersma IH; Oranje AP; Grimalt R; Iorizzo M; Piraccini BM; Verdonschot EH
    Indian J Dermatol Venereol Leprol; 2014; 80(6):521-5. PubMed ID: 25382509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia.
    Sato A; Takeda A
    J Dermatol; 2012 Jan; 39(1):27-32. PubMed ID: 21980923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up.
    Rossi A; Cantisani C; Scarnò M; Trucchia A; Fortuna MC; Calvieri S
    Dermatol Ther; 2011; 24(4):455-61. PubMed ID: 21910805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride.
    Jung JY; Yeon JH; Choi JW; Kwon SH; Kim BJ; Youn SW; Park KC; Huh CH
    Int J Dermatol; 2014 Nov; 53(11):1351-7. PubMed ID: 24898559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of herbal alternatives in androgenetic alopecia.
    Dhariwala MY; Ravikumar P
    J Cosmet Dermatol; 2019 Aug; 18(4):966-975. PubMed ID: 30980598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dutasteride in Androgenetic Alopecia: An Update.
    Arif T; Dorjay K; Adil M; Sami M
    Curr Clin Pharmacol; 2017; 12(1):31-35. PubMed ID: 28294070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year efficacy of finasteride in 801 Japanese men with androgenetic alopecia.
    Yoshitake T; Takeda A; Ohki K; Inoue Y; Yamawaki T; Otsuka S; Akimoto M; Nemoto M; Shimakura Y; Sato A
    J Dermatol; 2015 Jul; 42(7):735-8. PubMed ID: 25903108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia.
    Prager N; Bickett K; French N; Marcovici G
    J Altern Complement Med; 2002 Apr; 8(2):143-52. PubMed ID: 12006122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients.
    Moreno-Arrones OM; Becerra A; Vano-Galvan S
    Clin Exp Dermatol; 2017 Oct; 42(7):743-748. PubMed ID: 28691187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the treatment of male pattern hair loss.
    York K; Meah N; Bhoyrul B; Sinclair R
    Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
    [No Abstract]   [Full Text] [Related]  

  • 14. Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
    Lin JH; Chen WC
    Kaohsiung J Med Sci; 2002 Aug; 18(8):379-85. PubMed ID: 12476680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.
    Gupta AK; Mays RR; Dotzert MS; Versteeg SG; Shear NH; Piguet V
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2112-2125. PubMed ID: 29797431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily.
    Price VH; Menefee E; Sanchez M; Ruane P; Kaufman KD
    J Am Acad Dermatol; 2002 Apr; 46(4):517-23. PubMed ID: 11907500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgenetic alopecia; drug safety and therapeutic strategies.
    Motofei IG; Rowland DL; Baconi DL; Tampa M; Sârbu MI; Păunică S; Constantin VD; Bălălău C; Păunică I; Georgescu SR
    Expert Opin Drug Saf; 2018 Apr; 17(4):407-412. PubMed ID: 29363345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hot flashes in a young girl: a wake-up call concerning Serenoa repens use in children.
    Miroddi M; Carnì A; Mannucci C; Moleti M; Navarra M; Calapai G
    Pediatrics; 2012 Nov; 130(5):e1374-6. PubMed ID: 23027164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines on the use of finasteride in androgenetic alopecia.
    Mysore V; Shashikumar BM
    Indian J Dermatol Venereol Leprol; 2016; 82(2):128-34. PubMed ID: 26924401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic maintenance effect of finasteride 1 mg every other month regimen in androgenetic alopecia and study on the difference in response to finasteride treatment: A prospective cohort study.
    Kim KH; Kwon SH; Sim WY; Lew BL
    J Dermatol; 2024 Apr; 51(4):552-557. PubMed ID: 38293734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.